Vertex Pharmaceuticals (NASDAQ: VRTX) reports 978-share Rule 144 resale and insider sales
Rhea-AI Filing Summary
Vertex Pharmaceuticals (VRTX) Rule 144 notice reporting planned resale of 978 shares of common stock related to a Restricted Stock Vesting event dated 02/17/2025. The filing also lists recent sales by Joy Liu: 1,385 shares on 01/05/2026 for $621,629.55, 812 shares on 02/12/2026 for $375,282.04, 9,320 shares on 02/13/2026 for $4,557,480.00, and 892 shares on 03/02/2026 for $442,396.32.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 resale notice and recent open-market dispositions by an insider.
The filing lists a small planned resale of 978 shares tied to a Restricted Stock Vesting dated 02/17/2025, plus four reported sales by Joy Liu in early 2026 with aggregate proceeds shown in the filing. The transactions are recorded with sale dates and gross proceeds.
These items are administrative disclosures under Rule 144; the filing does not state any change to capital structure or company proceeds. Subsequent filings would show further disposition details if relevant.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
Gross proceeds financial
FAQ
What does the VRTX Form 144 report disclose?
How much did Joy Liu receive from the largest sale listed?